Influenza: evolving strategies in treatment and prevention
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsReverse Genetics Approaches for the Development of Influenza VaccinesImmunosenescence: deficits in adaptive immunity in the elderlyBench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentationInfluenza A virus attenuation by codon deoptimization of the NS gene for vaccine developmentβ-Glucan derived from Aureobasidium pullulans is effective for the prevention of influenza in miceEfficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study.H1N1 influenza A infectionPotential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.Pandemism of swine flu and its prospective drug therapy.Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection.The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase.G-quadruplexes in viruses: function and potential therapeutic applications.Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession.Influenza A virus inhibits alveolar fluid clearance in BALB/c micePathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.Oral administration of heat-killed Lactobacillus kunkeei YB38 improves murine influenza pneumonia by enhancing IgA production.Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in miceMycobacterium leprae Hsp65 administration reduces the lifespan of aged high antibody producer mice.Evolving gene targets and technology in influenza detection.Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.Swine flu virus H1N1: a threat to human health.Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.An alternative strategy as a quadrivalent live attenuated influenza virus vaccine
P2860
Q21090775-9349ECE4-6562-43C9-BB45-2904B9DD7A30Q28076140-12D2C2A4-C316-481C-8566-E0CC2F51A3CEQ28238448-BC786916-4B4F-47C9-9412-553E0F975A1EQ28386164-D789832B-28FD-4CF7-B2BE-635B0E21FEB9Q28395006-3EF779FC-1CE2-4A54-804F-211D7D8B7605Q28728950-211B4534-D408-4193-9690-ACF33388411CQ30354725-A0EA5546-9539-45E9-B77D-ED35FE8DF6EEQ30382598-5A02D20E-1A51-4451-9E7E-6F455A583C48Q30395281-11B80BDA-7DF5-485F-8139-A8C4869A6C06Q30420391-D9E3772E-D690-4773-8A9F-97FC633B3BB6Q33779595-0C0C406E-0BC9-4C6D-A20C-B32EA2D6546BQ34469957-D264F1FC-03BA-461A-8D2B-43EAEEE0EA57Q34489819-8E84090B-2E5F-4ADE-8FB1-EB8934AA2BFBQ35869278-3AA3803A-2170-47E2-8353-5B9EC7356326Q36256314-ED12B257-774D-419A-A918-D8515A08FC94Q36276683-BB6E806E-F105-4A5F-BFF3-0A829BA64272Q36953924-6309801A-6DAE-417C-BEA6-66F8D12A0490Q36960799-F79F67DD-BEBA-48D4-B102-7FE6A420EA21Q37029615-BDDAF6E1-3478-4644-9911-85A09A74D309Q37073339-483F7E29-51CA-44C2-96BF-023A7D205CE0Q37278611-00D727FF-728C-4FB2-9773-F3023DC40952Q37634776-7A703D75-F78A-4375-9AC1-6AEE2E56BB65Q37695467-414D4FB5-E0B2-4F8B-B808-B7040767FE13Q37703093-F99A2AA0-5EA2-4F3D-8D55-268462D7F547Q38107846-A8C6AC72-2AA9-407F-B6F4-03B555BB1D6FQ38841198-6206978F-C3FB-4F5D-BFCC-AF401B4B1E9EQ42092337-C6671398-DA57-4183-B27F-FA20DBF2C8A5Q42327028-9A5C5B3E-C5D4-46C9-920D-755236BDF61AQ45359885-8EAFB203-6246-4645-87E3-AC72FC7B092EQ57093877-E30D3FEB-D160-45B3-8046-6CBB8C4F262A
P2860
Influenza: evolving strategies in treatment and prevention
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Influenza: evolving strategies in treatment and prevention
@ast
Influenza: evolving strategies in treatment and prevention
@en
Influenza: evolving strategies in treatment and prevention
@nl
type
label
Influenza: evolving strategies in treatment and prevention
@ast
Influenza: evolving strategies in treatment and prevention
@en
Influenza: evolving strategies in treatment and prevention
@nl
prefLabel
Influenza: evolving strategies in treatment and prevention
@ast
Influenza: evolving strategies in treatment and prevention
@en
Influenza: evolving strategies in treatment and prevention
@nl
P356
P1476
Influenza: evolving strategies in treatment and prevention
@en
P2093
Edward E Walsh
Joseph P Lynch
P304
P356
10.1055/S-2007-976487
P407
P577
2007-04-01T00:00:00Z